Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 17, 2020 - Issue 4
Submit an article Journal homepage
455
Views
20
CrossRef citations to date
0
Altmetric
Review

Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension

Ali KeshavarzDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USAView further author information
,
Hossam KadryDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USAView further author information
,
Ahmed AlobaidaDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USAView further author information
&
Fakhrul AhsanDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, TX, USACorrespondence[email protected]
View further author information
Pages 439-461 | Received 14 Nov 2019, Accepted 10 Feb 2020, Published online: 19 Feb 2020

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maria Gabriella Matera, Luigino Calzetta, Josuel Ora, Paola Rogliani & Mario Cazzola. (2021) Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs. Expert Opinion on Drug Delivery 18:7, pages 891-906.
Read now

Articles from other publishers (19)

Yoogyeong Oh, Kyungtae Park, Sungwon Jung, Moonhyun Choi, Taihyun Kim, Yoojin Lee, Jae Young Choi, Yang‐Hee Kim, Se Yong Jung & Jinkee Hong. (2023) Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment. Small.
Crossref
Lydia R. Ware, Christine S. Kim, Paul M. Szumita & Jeremy R. DeGrado. (2023) A Narrative Review on the Administration of Inhaled Prostaglandins in Critically Ill Adult Patients With Acute Respiratory Distress Syndrome. Annals of Pharmacotherapy.
Crossref
Elaheh Mirhadi, Prashant Kesharwani, Thomas P. Johnston & Amirhossein Sahebkar. (2023) Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension. Drug Discovery Today 28:6, pages 103599.
Crossref
Fatma Haddad, Nura Mohammed, R. C. Gopalan, Yousef Al Ayoub, Md Talat Nasim & K. H. Assi. (2023) Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach. Pharmaceutics 15:2, pages 539.
Crossref
Ivana Stolfa & Clive Page. 2023. Pulmonary Pharmacology. Pulmonary Pharmacology 55 81 .
Muhammad Afzal, Imran Kazmi, Rupinder Kaur, Salman Bakr I. Hosawi, Mohammed Kaleem, Sami I. Alzarea & Muhammad Masood Ahmad. 2023. How Synthetic Drugs Work. How Synthetic Drugs Work 1 25 .
Bassant Elbardisy, Nabila Boraie & Sally Galal. (2022) Tadalafil Nanoemulsion Mists for Treatment of Pediatric Pulmonary Hypertension via Nebulization. Pharmaceutics 14:12, pages 2717.
Crossref
Unnati Kumbhare, Pallavi Yelne & Sanket Tekale. (2022) Therapeutic Use of an Inhaled Drug Delivery in Pulmonary Hypertension: A Review. Cureus.
Crossref
Raul Edison Luna Lazo, Mariana Mengarda, Susana Leão Almeida, Aline Caldonazo, Joel Toribio Espinoza & Fábio Seigi Murakami. (2022) Advanced formulations and nanotechnology-based approaches for pulmonary delivery of sildenafil: A scoping review. Journal of Controlled Release 350, pages 308-323.
Crossref
Lai-Hao Qu, Wen-Juan Luo, Zhi-Guo Yan & Wen-Pan Liu. (2022) FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension. Mediators of Inflammation 2022, pages 1-24.
Crossref
Monica-Carolina Villa-Hermosilla, Sofia Negro, Emilia Barcia, Carolina Hurtado, Consuelo Montejo, Mario Alonso & Ana Fernandez-Carballido. (2022) Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome. Pharmaceutics 14:7, pages 1392.
Crossref
Vinit Agnihotri, Yogeeta Agrawal, Sameer Goyal, Charu Sharma & Shreesh Ojha. (2022) An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension. Molecules 27:11, pages 3490.
Crossref
Deepthi Alapati & Thomas H. Shaffer. (2022) Administration of Drugs/Gene Products to the Respiratory System: A Historical Perspective of the Use of Inert Liquids. Frontiers in Physiology 13.
Crossref
Adam J. Plaunt, Tam L. Nguyen, Michel R. Corboz, Vladimir S. Malinin & David C. Cipolla. (2022) Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery. Pharmaceutics 14:2, pages 302.
Crossref
Peter Sandner, Markus Follmann, Eva Becker‐Pelster, Michael G. Hahn, Christian Meier, Cecilia Freitas, Lothar Roessig & Johannes‐Peter Stasch. (2021) Soluble GC stimulators and activators: Past, present and future. British Journal of Pharmacology.
Crossref
Aoqi Li, Jin He, Zhe Zhang, Sibo Jiang, Yun Gao, Yuchun Pan, Huanan Wang & Lenan Zhuang. (2021) Integrated Bioinformatics Analysis Reveals Marker Genes and Potential Therapeutic Targets for Pulmonary Arterial Hypertension. Genes 12:9, pages 1339.
Crossref
Ali Keshavarz, Hossam Kadry, Ahmed Alobaida, Md Nurunnabi & Taslim A. Al-Hilal. 2021. Bioinspired and Biomimetic Materials for Drug Delivery. Bioinspired and Biomimetic Materials for Drug Delivery 241 276 .
Taslim A. Al-Hilal, Ali Keshavarz, Hossam Kadry, Behnaz Lahooti, Ahmed Al-Obaida, Zhenya Ding, Wei Li, Roger Kamm, Ivan F. McMurtry, Tim Lahm, Eva Nozik-Grayck, Kurt R. Stenmark & Fakhrul Ahsan. (2020) Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application. Lab on a Chip 20:18, pages 3334-3345.
Crossref
Rita B. Restani, Rita F. Pires, Pedro V. Baptista, Alexandra R. Fernandes, Teresa Casimiro, Vasco D. B. Bonifácio & Ana Aguiar‐Ricardo. (2020) Nano‐in‐Micro Sildenafil Dry Powder Formulations for the Treatment of Pulmonary Arterial Hypertension Disorders: The Synergic Effect of POxylated Polyurea Dendrimers, PLGA, and Cholesterol. Particle & Particle Systems Characterization 37:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.